Conference Coverage
Trending on Contemporary OB/GYN
Phase 1 trial shows promise for triple-negative breast cancer vaccine
Pregnancy-specific guidance clarifies antiseizure medication management
Planned early-term birth reduces preeclampsia risk
No evidence links menopause hormone therapy to dementia risk
US gestational diabetes rates rise 36% since 2016
Latest News
Shorts










Podcasts

Pap Talk S4E15: MIRA surgical system for hysterectomy with Jean Dubuisson, MD, PhD
In this episode of Pap Talk, Jean Dubuisson, MD, PhD, discusses the first successful hysterectomy performed using the MIRA surgical system.

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 2
This is part 2 of a 2-part series. In this bonus episode of Pap Talk, get an exclusive recap of Kimberly Kho, MD's presentation from AAGL 2022 on alternatives to hysterectomy and uterine-preserving options for fibroids.

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 1
This is part 1 of a 2-part series. In this bonus episode of Pap Talk, get an exclusive recap of Kimberly Kho, MD's presentation from AAGL 2022 on alternatives to hysterectomy and uterine-preserving options for fibroids.

Recap on reproductive rights with David Hackney, MD, MS
In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.

Pap Talk: Bonus episode S4E11: EMIGS with Dr. Nash Moawad
In this bonus episode, Nash Moawad, MD, MS, FACOG, FACS, sits down to discuss the recent standardization of Essentials of Minimally Invasive Gynecologic Surgery (EMIGS) training program for minimally invasive gynecologic surgeons and how it's shaping the way this subspecialty delivers care.

Pap Talk S4E10: 2023 women's health outlook
In this episode of Pap Talk, Alison Cowan, MD, discusses her predictions for women's health trends in 2023.

Pap Talk: The impact of environmental exposures on women's health
From safe baby products to helping your patients become educated consumers, Huffling's insights are valuable across practices.

Pap Talk: Medications for early pregnancy loss with Amy Levi, CNM, WHNP-BC, FACNM, FAAN
Amy Levi, CNM, WHNP-BC, FACNM, FAAN, Albers Endowed Professor of Midwifery at the University of New Mexico College of Nursing, sits down to discuss her presentation at the NPWH 25th Annual Premier Women's Healthcare Conference on medications for early pregnancy loss.

Pap Talk: Medications for early pregnancy loss
In this episode of Pap Talk, Amy Levi, CNM, WHNP-BC, FACNM, FAAN, Albers Endowed Professor of Midwifery at the University of New Mexico College of Nursing, sits down to discuss her presentation at the NPWH 25th Annual Premier Women's Healthcare Conference on medications for early pregnancy loss.

Vaginismus: Managing a Misunderstood and Underdiagnosed Condition
Tune into this valuable discussion with host Scott Kober and experts Rachel Pope, MD, MPH, and Sheryl Kingsberg, PhD, as they highlight the overall impact of vaginismus and discuss strategies to combat its effects on women who are diagnosed the condition.
Videos
Continuing Medical Education
All News

New guidelines provide recommendations for adjusting antiseizure medication doses during pregnancy and postpartum to support healthy outcomes.

New research links abnormal collagen remodeling at cesarean scars—not placental invasion—to placenta accreta spectrum risk.

A study links opioid-related diagnoses during pregnancy to increased maternal morbidity and neonatal complications.

A study found no clear evidence that menopause hormone therapy increases or reduces dementia risk.

Criteria-independent genetic testing identifies more women with pathogenic breast cancer variants than guideline-based approaches.

A study found that an investigational α-lactalbumin–targeting vaccine induced immune responses in 74% of participants at risk for triple-negative breast cancer.

A study found HPV vaccination is linked to reduced odds of severe vulvar and vaginal precancerous lesions.

New research shows that COVID-19 vaccination in pregnancy significantly lowers the risk of hospitalization and preterm delivery.

Take a quick look at everything you may have missed during the fourth quarter of 2025, including the latest FDA approvals and top stories.

Check out the biggest approvals in women's health during 2025.

Take a quick look at everything you may have missed in December, including the latest FDA updates, top stories, and expert recommendations.

Take a quick look at everything you may have missed in 2025, including the latest FDA updates, top stories, and expert recommendations.

Check the top women's health conferences of 2025.

Check out the 5 biggest videos of 2025, and review best practices.

Check out the 5 biggest well woman articles of 2025, and review best practices.

Check out the 5 biggest contraception stories of 2025, and review best practices.

Check out the 5 biggest fertility stories of 2025, and review best practices.

Check out the 5 biggest menopause stories of 2025, and review best practices.

Check out the 5 biggest obstetrics stories of 2025, and review best practices.

Check out the 5 biggest gynecology stories of 2025, and review best practices.

Can you guess what condition Tiny Tim had?

A study found that intimate partner violence and sexual violence against children drive substantial global mortality and disability.

Prenatal exposure to hot, humid conditions was associated with significantly reduced child growth, with effects far greater than heat alone.

CBD and THC reduced ovarian cancer cell growth and migration in vitro, with strongest effects seen when the compounds were combined in equal ratios.

Research suggests mesenchymal stem cell therapy may improve sexual quality of life and overall health span in older women.

A study found widespread nonadherence to cervical cancer screening guidelines, with screening modality linked to overscreening and underscreening.

Higher intake of ultra-processed foods before diagnosis was associated with increased breast cancer–specific and all-cause mortality in Black women.

A study found hydroxyurea exposure during pregnancy was not associated with increased risks among patients with sickle cell disease.

Recent FDA approvals and emerging research highlight how neurokinin receptor antagonists are expanding nonhormonal options for managing vasomotor symptoms.

Explore the latest findings on copper IUDs, including new options and efficacy data, shaping the future of non-hormonal contraception.

Advances including FDA-approved neurokinin receptor antagonists are reshaping vasomotor symptom management by providing effective, nonhormonal options for menopausal women.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Michelle Manzo, MPH, CMPP, outlines key challenges and care strategies for women with epilepsy across pregnancy and parenthood.

























